Structure-activity relationship of verapamil analogs and reversal of multidrug resistance
- 12 October 1995
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 50 (8) , 1245-1255
- https://doi.org/10.1016/0006-2952(95)02003-u
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- The multidrug‐resistance‐reverser verapamil interferes with cellular P‐glycoprotein‐mediated pumping of daunorubicin as a non‐competing substrateEuropean Journal of Biochemistry, 1994
- Non-competitive inhibition of P-glycoprotein-associated efflux of THP-adrimycin by verapamil in living K562 leukemia cellsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Increased chemosensitivity to doxorubicin of intrinsically multidrug-resistant human colon carcinoma cells by prolonged exposure to verapamilEuropean Journal Of Cancer, 1993
- Mechanism of multidrug resistance in human tumour cell lines and complete reversion of cellular resistanceEuropean Journal Of Cancer, 1992
- Photoaffinity Labeling of P-Glycoprotein in Multidrug-Resistant CellsCancer Investigation, 1992
- Reversal of multi‐drug resistance in human KB cell lines by structural analogs of verapamilInternational Journal of Cancer, 1990
- D‐verapamil and L‐verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitroInternational Journal of Cancer, 1988
- The effect of dextro-, levo-, and racemic verapamil on atrioventricular conduction in humansAmerican Heart Journal, 1985